Comparing warfarin to aspirin (WoA) after aortic valve replacement with the St. Jude Medical Epic™ heart valve bioprosthesis: Results of the WoA epic pilot trial

Journal of Heart Valve Disease

Volumn 16, Issue 6, 2007, Pages 667-671

  Colli, Andrea ^a   Mestres, Carlos A ^a   Castella, Manuel ^a   Gherli, Tiziano ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

AGED; AORTA STENOSIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ARTICLE; BLEEDING; BRAIN ISCHEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; DISEASE DURATION; DISEASE FREE SURVIVAL; DRUG EFFICACY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HEART ATRIUM FIBRILLATION; HEART VALVE BIOPROSTHESIS; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OVERALL SURVIVAL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAINT JUDE HEART VALVE PROSTHESIS; SINUS RHYTHM; STROKE; SURGICAL RISK; THROMBOEMBOLISM; TREATMENT DURATION;

AGED; ANTICOAGULANTS; AORTIC VALVE; ASPIRIN; BIOPROSTHESIS; FEMALE; HEART VALVE PROSTHESIS; HUMANS; MALE; PILOT PROJECTS; POSTOPERATIVE CARE; THROMBOSIS; WARFARIN;

EID: 36949038989     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Heras M, Chesebro JH, Fuster V, et al. High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol 1995;25:1111-1119
2. Gherli T, Colli A, Fragnito C, et al. Comparing warfarin with aspirin after biological aortic valve replacement: A prospective study. Circulation 2004;110:496-500
3. Edmunds LM, Clark RE, Cohn LM, Miller DC, Weiser R. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1988;46:257-259
4. Bonow RO, Carabello B, de Leon AC, Jr., et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 2006;48:598-675
5. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28:230-268
6. Salem DN, Stein PD, Al-Ahmad A, et al. Antithrombotic therapy in valvular heart disease - native and prosthetic: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3Suppl.):457S-482S
7. Jamieson WR, Cartier CP, Allard M. Surgical management of valvular heart disease Can J Cardiol 2004;20(Suppl.E):15
8. Turpie AG, Gunstensen J, Hirsh J, Nelson H, Gent M. Randomised comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement. Lancet 1988;1:1242-1245
9. Babin-Ebell J, Schmidt W, Eigel P, Elert O. Aortic bioprosthesis without early anticoagulation risk of thromboembolism. Thorac Cardiovasc Surg 1995;43:212-214
10. Joyce LD, Nelson RM. Comparison of porcine valve xenografts with mechanical prostheses: A 71/2-year experience. J Thorac Cardiovasc Surg 1984;88:102-113
11. Blair KL, Hatton AC, White DW, et al. Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement. Circulation 1994;90(5Pt.2):II214-II219
12. Gallo I, Ruiz B, Duran CM. Five- to eight-year follow-up of patients with the Hancock cardiac bioprosthesis. J Thorac Cardiovasc Surg 1983;86:897-902
13. Revuelta JM, Duran CM. Performance of the lonescu-Shiley pericardial valve in the aortic position: 100 months' clinical experience. Thorac Cardiovasc Surg 1986;34:247-251
14. Moinuddeen K, Quin J, Shaw R, et al. Anticoagulation is unnecessary after biological aortic valve replacement. Circulation 1998;98(19 Suppl.):II95-II98
15. Sundt TM, Zehr KJ, Dearani JA, et al. Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement? J Thorac Cardiovasc Surg 2005;129:1024-1031
16. Aramendi JI, Mestres CA, Martinez-Leon J, Campos V, Munoz G, Navas C. Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (TRAC): Prospective, randomized, co-operative trial. Eur J Cardiothorac Surg 2005;27:854-860
17. Orszulak TA, Schaff HV, Mullany CJ, et al. Risk of thromboembolism with the aortic Carpentier-Edwards bioprosthesis. Ann Thorac Surg 1995;59:462-468
18. Tiede DJ, Nishimura RA, Gastineau DA, et al. Modern management of the prosthetic valve anticoagulation. Mayo Clin Proc 1998;73:665-680